Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer.

Scherr AL, Mock A, Gdynia G, Schmitt N, Heilig CE, Korell F, Rhadakrishnan P, Hoffmeister P, Metzeler KH, Schulze-Osthoff K, Illert AL, Boerries M, Trojan J, Waidmann O, Falkenhorst J, Siveke J, Jost PJ, Bitzer M, Malek NP, Vecchione L, Jelas I, Brors B, Glimm H, Stenzinger A, Grekova SP, Gehrig T, Schulze-Bergkamen H, Jäger D, Schirmacher P, Heikenwalder M, Goeppert B, Schneider M, Fröhling S, Köhler BC

Open source

DOI: 10.1038/s41419-020-03092-7
Published: 2020 Oct 17
Container: Cell death & disease
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41419-020-03092-7,
  title = {Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer.},
  author = {Scherr AL and Mock A and Gdynia G and Schmitt N and Heilig CE and Korell F and Rhadakrishnan P and Hoffmeister P and Metzeler KH and Schulze-Osthoff K and Illert AL and Boerries M and Trojan J and Waidmann O and Falkenhorst J and Siveke J and Jost PJ and Bitzer M and Malek NP and Vecchione L and Jelas I and Brors B and Glimm H and Stenzinger A and Grekova SP and Gehrig T and Schulze-Bergkamen H and Jäger D and Schirmacher P and Heikenwalder M and Goeppert B and Schneider M and Fröhling S and Köhler BC},
  year = {2020},
  journal = {Cell death \& disease},
  doi = {10.1038/s41419-020-03092-7},
  url = {https://doi.org/10.1038/s41419-020-03092-7}
}

RIS

TY  - JOUR
TI  - Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer.
AU  - Scherr AL
AU  - Mock A
AU  - Gdynia G
AU  - Schmitt N
AU  - Heilig CE
AU  - Korell F
AU  - Rhadakrishnan P
AU  - Hoffmeister P
AU  - Metzeler KH
AU  - Schulze-Osthoff K
AU  - Illert AL
AU  - Boerries M
AU  - Trojan J
AU  - Waidmann O
AU  - Falkenhorst J
AU  - Siveke J
AU  - Jost PJ
AU  - Bitzer M
AU  - Malek NP
AU  - Vecchione L
AU  - Jelas I
AU  - Brors B
AU  - Glimm H
AU  - Stenzinger A
AU  - Grekova SP
AU  - Gehrig T
AU  - Schulze-Bergkamen H
AU  - Jäger D
AU  - Schirmacher P
AU  - Heikenwalder M
AU  - Goeppert B
AU  - Schneider M
AU  - Fröhling S
AU  - Köhler BC
PY  - 2020
JO  - Cell death & disease
DO  - 10.1038/s41419-020-03092-7
UR  - https://doi.org/10.1038/s41419-020-03092-7
ER  -

APA

AL, S., A, M., G, G., N, S., CE, H., F, K., P, R., P, H., KH, M., K, S., AL, I., M, B., J, T., O, W., J, F., J, S., PJ, J., M, B., NP, M., L, V., I, J., B, B., H, G., A, S., SP, G., T, G., H, S., D, J., P, S., M, H., B, G., M, S., S, F., & BC, K. (2020). Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer.. Cell death & disease. https://doi.org/10.1038/s41419-020-03092-7

Source records

pubmed · retrieved 2026-09-26T18:51:06.176Z